{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T07:07:37Z","timestamp":1649142457704},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1007\/bf02825833","type":"journal-article","created":{"date-parts":[[2008,2,11]],"date-time":"2008-02-11T05:42:24Z","timestamp":1202708544000},"page":"356-358","source":"Crossref","is-referenced-by-count":1,"title":["Precocious pseudopuberty with testicular enlargement"],"prefix":"10.1007","volume":"73","author":[{"given":"R.","family":"Rajput","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bhansali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Sialy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02825833_CR1","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1542\/peds.104.4.936","volume":"104","author":"PB Kaplowit","year":"1999","unstructured":"Kaplowit PB, Oberfield SE. Reexamination of age limit for defining when puberty is precocious in girls in United States: implications for evaluation and treatment. Drug and Therapeutic and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society.Pediatrics 1999; 104: 936\u2013941.","journal-title":"Pediatrics"},{"key":"BF02825833_CR2","doi-asserted-by":"crossref","unstructured":"Marke DP, Cutler GB Jr. Evaluation and management of Precocious puberty.Arch Dis Child 1996: 296\u2013371.","DOI":"10.1136\/adc.75.4.269"},{"key":"BF02825833_CR3","doi-asserted-by":"crossref","unstructured":"Low LC, Wang Q: Gonadotropin indepaendent precocious puberty.J Pediatr Endocrinol Metab 1998: 497\u2013507.","DOI":"10.1515\/JPEM.1998.11.4.497"},{"key":"BF02825833_CR4","first-page":"1219","volume-title":"Williams's textbook of Endocrinology","author":"Melvin M Grumbach","year":"2003","unstructured":"Melvin M Grumbach, Dennis MStyne. Puberty: Ontogeny, meuroendocronology, physiology and disorders. In Larsen, Kronenberg, Metmed, polonsky, eds.Williams's textbook of Endocrinology. Philadelphia; WB Saunders, 2003; 1219\u20131221."},{"key":"BF02825833_CR5","first-page":"990","volume":"109","author":"CA Egli","year":"1985","unstructured":"Egli CA, Rosenthal SM, Grumbach MMet al. Pituitiary gonadotropin-independent male-limited autosomal domonant sexual precocity in nine generations: familial testotoxicosis.Arch Pathol Lab Med 1985; 109: 990\u2013995.","journal-title":"Arch Pathol Lab Med"},{"key":"BF02825833_CR6","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/365652a0","volume":"365","author":"A Shenker","year":"1993","unstructured":"Shenker A, Laue L, Kosugi Set al. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty.Nature 1993; 365: 652\u2013654.","journal-title":"Nature"},{"key":"BF02825833_CR7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJM198902233200805","volume":"320","author":"L Laue","year":"1989","unstructured":"Laue L, Kenigsberg D, Pescovitz OH. Treatment of familial male precocious puberty with spironolactone and testolactone.N Engl J Med 1989; 320: 498\u2013502.","journal-title":"N Engl J Med"},{"issue":"1","key":"BF02825833_CR8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/jcem.84.1.5413","volume":"84","author":"EW Leschek","year":"1999","unstructured":"Leschek EW, Jones J, Barnes KMet al. Six year results of spironolactone ans testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty onset.J Clin Endocrinol Metab 1999; 84 (1): 175\u2013178.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02825833.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02825833\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02825833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T13:32:59Z","timestamp":1558445579000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02825833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["BF02825833"],"URL":"https:\/\/doi.org\/10.1007\/bf02825833","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}